Question 1

Does Barclays own TRVI stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 1,142,077 shares of TRVI (Trevi Therapeutics), worth $21.3M.

Question 2

How many shares of TRVI does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 1,142,077 shares of TRVI (Trevi Therapeutics).

Question 3

What is Barclays' TRVI position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' TRVI position is worth $21.3M.

Question 4

Is Barclays buying or selling TRVI?

Accepted Answer

In Q2 2026, Barclays increased its TRVI position from 53,585 to 1,142,077 shares.

Question 5

When did Barclays first buy TRVI?

Accepted Answer

Barclays first reported TRVI in its Q2 2020 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.1M	+2031.3%	$21.3M	0.0%	$18.65	46
2026-Q1	Decreased	53,585	-90.8%	$639,268	0.0%	$12.26	0
2025-Q4	Increased	582,653	+168.7%	$7.3M	0.0%	$12.56	44
2025-Q3	Decreased	216,885	-57.9%	$2M	0.0%	$8.95	0
2025-Q2	Increased	515,476	+273.7%	$2.8M	0.0%	$5.62	42
2025-Q1	Decreased	137,932	-11.7%	$867,593	0.0%	$6.50	0
2024-Q4	Increased	156,267	+64.1%	$643,820	0.0%	$4.10	36
2024-Q3	Increased	95,232	+180.8%	$318,075	0.0%	$3.33	38

TRVIShowing 8 of 18 quarters

TRVI
Showing 8 of 18 quarters